HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .

Abstract
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary arterial hypertension (PAH). Because of the similar clinical picture of dyspnea on exertion and signs of right heart failure, PVOD is difficult to distinguish from idiopathic PAH. However, the distinction is mandatory because PVOD has a worse prognosis and, more importantly, the administration of PAH specific therapy (vasodilators) can precipitate severe acute pulmonary oedema. We present a challenging case of PAH in a patient with systemic sclerosis in whom a marked decrease in functional capacity after the initiation of bosentan therapy led to the diagnosis of PVOD. Management of PVOD patients is challenging and referral for lung transplantation should be done at the moment of diagnosis.
AuthorsAna Maria Daraban, Roxana Enache, L Predescu, P Platon, T Constantinescu, Carina Mihai, I M Coman, Carmen Ginghina, Ruxandra Jurcuţ
JournalRomanian journal of internal medicine = Revue roumaine de médecine interne (Rom J Intern Med) 2015 Apr-Jun Vol. 53 Issue 2 Pg. 175-83 ISSN: 1220-4749 [Print] Romania
PMID26402988 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Female
  • Humans
  • Hypertension, Pulmonary (etiology)
  • Middle Aged
  • Pulmonary Veno-Occlusive Disease (complications, diagnosis)
  • Scleroderma, Systemic (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: